Study of BL-M08D1 for returning blood cancers
Part of Blood & lymphatic clinical trials.
This trial tests a new drug called BL-M08D1 for people with lymphoma or other blood cancers that came back or didn't respond to standard treatments. It aims to see if the drug can help when other options are no longer working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old
- Your lymphoma or blood cancer has come back or not responded to at least one prior treatment and no standard treatment is available
- You must be willing to provide a tumor sample from past biopsy or a new one if possible
- You must have good organ function, including heart, liver, kidneys, and blood clotting
- You cannot have serious heart disease, uncontrolled high blood pressure, diabetes complications, or active infections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This trial tests an experimental drug called BL-M08D1 for people with solid tumors that have spread or cannot be removed by surgery and have stopped responding to standard treatments. The goal is to see if the drug is safe and effective.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This study tests a new drug combined with standard chemotherapy and immune therapy for people with diffuse large B-cell lymphoma. The goal is to see if the combination is safe and helps shrink or control the cancer.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
Hear when a new Relapsed or Refractory Lymphoid Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.